Both in Biotechnology
Ginkgo Bioworks Holdings vs Sana Biotechnology
Over the past year DNA returned +0.5% and SANA returned −38.3%; their daily moves had a correlation of 0.44.
DNA +0.5% SANA −38.3%Growth of $1, one year, split-adjusted
| Metric | DNA | SANA |
|---|---|---|
| Price | $11.65 | $2.56 |
| Market cap | $784.5M | $766.4M |
| Today | +8.27% | +4.92% |
| 1 month | −6.1% | −6.9% |
| 6 months | +15.6% | −29.7% |
| Year to date | +40.2% | −37.1% |
| 1 year | −8.9% | −44.0% |
| Revenue growth (YoY) | −48.5% | — |
| Gross margin | 91.5% | — |
| Net margin | −231.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.0× | — |
| Net cash | $302.2M | $160.5M |
| Dividend yield | — | — |
| Volatility (60d) | 128.9% | 72.6% |
| Short % of float | 18.4% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).